New Clinical Trial for Myelofibrosis Patients with JAK2 Mutation Promising results are being found in a new clinical trial for JAK2 mutation positive myelofibrosis patients. Andrew Schorr, Srinivas K. Tantravahi, MBBS, MRCP
Hereditary Trends in MPNs Does my risk for having an MPN increase if a close relative is diagnosed? Angela Fleischman, MD, PhD, Esther Schorr
Myeloproliferative Neoplasms in Children and Young Adults Esther Schorr, Nicole Kucine, MD, Portia Pliam
ASH 2020 MPN Daily Wrap-Up: New Research and Early Detection Andrew Schorr, Esther Schorr, Naveen Pemmaraju, MD, Michael Mauro, MD
The Leading Edge of Myeloproliferative Neoplasms Treatment Ruth Fein, Srdan Verstovsek, MD, PhD, Andrew Schorr
MPN Experts Discuss Clinical Trials and Transplants Jeanne Palmer, MD, Naveen Pemmaraju, MD, Phil Arner, Andrew Schorr